Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -109,845 | -71,243 | -34,069 | -135,840 | -102,726 |
| Depreciation Amortization | -6,052 | -3,378 | -1,481 | 2,369 | 2,817 |
| Other Working Capital | 4,108 | -929 | -7,275 | -2,982 | -3,136 |
| Other Operating Activity | 21,273 | 14,061 | 6,953 | 26,391 | 19,513 |
| Operating Cash Flow | $-90,516 | $-61,489 | $-35,872 | $-110,062 | $-83,532 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,486 | -35,065 | 11,165 | 33,253 | 80,559 |
| PPE Investments | -152 | -132 | -36 | -626 | -614 |
| Investing Cash Flow | $-26,638 | $-35,197 | $11,129 | $32,627 | $79,945 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | N/A |
| Common Stock Issued | 94,092 | 94,008 | N/A | 29,140 | 3,852 |
| Other Financing Activity | 0 | 0 | 0 | -575 | 0 |
| Financing Cash Flow | $94,092 | $94,008 | $N/A | $38,565 | $3,852 |
| Beginning Cash Position | 51,802 | 51,802 | 51,802 | 90,672 | 90,672 |
| End Cash Position | 28,740 | 49,124 | 27,059 | 51,802 | 90,937 |
| Net Cash Flow | $-23,062 | $-2,678 | $-24,743 | $-38,870 | $265 |
| Free Cash Flow | |||||
| Operating Cash Flow | -90,516 | -61,489 | -35,872 | -110,062 | -83,532 |
| Capital Expenditure | -152 | -132 | -36 | -626 | -614 |
| Free Cash Flow | -90,668 | -61,621 | -35,908 | -110,688 | -84,146 |